Search results
Study opens the door to designing therapies to improve lung development in growth-restricted fetuses
Medical Xpress· 36 minutes agoThis is the focus of research led jointly by the BCNatal Fetal Medicine Research Center (Hospital...
First WVU Medicine Children’s heart patient successfully receives Harmony Valve
WDTV· 40 minutes agoA 16-year-old from Frostburg, Maryland was WVU Medicine Children’s first recipient of the Harmony...
Yes, Spices Can Help You Lose Weight—Start With These 15 Options
Parade via AOL· 2 hours agoA more recent review published in 2021 in Pharmacological Research - Modern Chinese Medicine...
Insider Buying: Editas Medicine, Inc. (NASDAQ:EDIT) Director Buys $253,800.00 in Stock
ETF DAILY NEWS· 10 hours agoEditas Medicine, Inc. (NASDAQ:EDIT – Get Free Report) Director Jessica Hopfield bought 45,000 shares of the firm’s stock in a transaction on Monday, May 13th. The shares were ...
Chad Daybell trial: Judge rules charge for murder of Lori Vallow’s son will stand despite clerical...
The Independent via Yahoo News· 4 hours agoDefence attorney John Prior said in opening statements that he would present several experts in DNA,...
Praxis Precision Medicines, Inc. to Post Q1 2025 Earnings of ($1.89) Per Share, HC Wainwright...
ETF DAILY NEWS· 11 hours agoPraxis Precision Medicines, Inc. (NASDAQ:PRAX – Free Report) – Investment analysts at HC Wainwright issued their Q1 2025 EPS estimates for Praxis Precision Medicines ...
Opinion: I asked several people well past retirement age why they keep working. Here’s what they...
CNN via Yahoo News· 3 hours agoIt’s no exaggeration to say that Dr. Howard Tucker has worked inmedicine for a lifetime. The average...
Opinion | Reflecting on Two Decades in Medicine: Advice to New Graduates
MedPage Today· 1 day agoBetween the 2022-2023 and the 2023-2024 academic years, the number of college graduates applying to...
EU regulator scraps approval for pregnancy drug over cancer risk
Reuters· 5 hours agoThe European Medicines Agency (EMA) on Friday recommended scrapping approval for a drug used to...
Editas Medicine, Inc. (NASDAQ:EDIT) Consensus Forecasts Have Become A Little Darker Since Its Latest...
Simply Wall St. via Yahoo Finance· 5 days agoEditas Medicine, Inc. (NASDAQ:EDIT) just released its latest quarterly report and things are not...